Zhang, Shiqi
Hagens, Laura A.
Heijnen, Nanon F. L.
Smit, Marry R.
Brinkman, Paul
Fenn, Dominic
van der Poll, Tom
Schultz, Marcus J.
Bergmans, Dennis C. J. J.
Schnabel, Ronny M.
Bos, Lieuwe D. J.
Bos, Lieuwe D. J.
Hagens, Laura A.
Schultz, Marcus J.
Smit, Marry R.
Bergmans, Dennis C. J. J.
Heijnen, Nanon F. L.
Schnabel, Ronny M.
Geven, Inge
Nijsen, Tamara M. E.
Verschueren, Alwin R. M.
,
Funding for this research was provided by:
China Scholarship Council (202106240048)
Amsterdam UMC fellowship
Article History
Received: 24 October 2023
Accepted: 18 March 2024
First Online: 23 March 2024
Declarations
:
: Summary conflict of interest statements: LDJB reports grants from: Dutch lung foundation (Dirkje Postma Award), Innovation Medicine Initiative (COVID-19 call), grants from Amsterdam UMC fellowship, Health Holland via lung foundation (PPP grant) and ZonMW (VIDI, COVID-19 urgency grants). LDJB reports participating in an advisory board for Sobi, Impentri, Novartis, CSL Behring and Astra Zeneca, all paid to institution. LDJB reports consultancy for Scailyte, who paid to institution, outside the submitted work. PB reports grants from: Amsterdam UMC (Innovation Impuls 2020 Grant), Vertex (Vertex Innovation Award 2022 Grant), Stichting Astma Bestrijding (SAB) Grant, Boehringer Ingelheim Grant, Eurostars, Horizon Europe Framework Programme (HORIZON) Grant. RS reports grant from: Dutch lung foundation (Young investigator grant). LAH, NFLH, MRS, DWF, MJS, DCJJB, and TvdP have no conflict of interest regarding this manuscript.
: This study was approved by the institutional review board and biobank review board of the Academic Medical Center, Amsterdam, The Netherlands, and of the Maastricht University Medical Center+ , Maastricht, The Netherlands (W18_311 #18.358 and 2019–1137). The study was registered with the “DARTS study” tag at the Dutch trial register (NL8226, ExternalRef removed).